Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2016 0 · FY2017 0 · FY2018 0
Operates in Healthcare Services — General medicine - private practice. Per the activity note to the FY2024 annual report, the company provides comprehensive medical services including laboratory, dermatology, endocrinology, neurology, and oncology services. Founded in 2011. Offers full-service ambulatory laboratory and medical specialist consultations.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 10,833 | 5,460 | 5,997 | 6,355 | 7,393 | 7,077 | 7,881 | 11,479 | +0.8% | |
| 1,307 | 194 | 0 | 0 | 0 | 0 | 0 | 0 | -85.2% | |
| Gross Profit | 9,526 | 5,267 | 5,997 | 6,355 | 7,393 | 7,077 | 7,881 | 11,479 | +2.7% |
| Gross Margin | 87.9% | 96.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,497 | 5,541 | 6,402 | 6,007 | 6,922 | 6,795 | 7,160 | 10,007 | +31.2% | |
| EBITDA | 8,029 | 275 | 405 | 348 | 471 | 282 | 721 | 1,473 | -21.5% |
| EBITDA Margin | 74.1% | 5.0% | 6.8% | 5.5% | 6.4% | 4.0% | 9.1% | 12.8% | |
| Total D&A | 1,109 | 275 | 246 | 222 | 195 | 233 | 179 | 268 | -18.3% |
| EBIT / Operating Income | 6,920 | 550 | 651 | 126 | 277 | 49 | 541 | 1,204 | -22.1% |
| Total Interest Income | 0 | 8 | 13 | 7 | 10 | 7 | 13 | 14 | +9.6% |
| Total Interest Expense | 730 | 22 | 48 | 42 | 34 | 19 | 24 | 1,005 | +4.7% |
| 0 | 19 | 31 | 436 | 532 | 58 | 11 | 429 | +67.6% | |
| Profit Before Tax | 6,189 | 583 | 717 | 527 | 784 | 95 | 519 | 216 | nmf |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 87 | 1 | -98.4% |
| Net Profit / (Loss) | 166 | 11 | 490 | 286 | 572 | 337 | 562 | 217 | nmf |
| Net Margin | 1.5% | 0.2% | 8.2% | 4.5% | 7.7% | 4.8% | 7.1% | 1.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →